Mack Gill
Direktor/Vorstandsmitglied bei ALTIMMUNE, INC.
Vermögen: 20 810 $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mitchel Sayare | M | 76 |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 14 Jahre |
| Vipin K. Garg | M | 67 | 6 Jahre | |
| David Drutz | M | 86 | 14 Jahre | |
| Philip Hodges | M | 56 | 21 Jahre | |
| Andrew Shutterly | M | 36 | 4 Jahre | |
| Brian Collings | M | - |
Torstone Technology Ltd.
 Torstone Technology Ltd. Packaged SoftwareTechnology Services Torstone Technology Ltd. provides cross-asset securities and derivatives post-trade processing technology. The firm develops sell-side post-trade processing platform for multiple asset classes. Its services include hosting, consultancy, support and development & integration. The company was founded in January 12, 2011 and is headquartered in London, the United Kingdom. | 13 Jahre |
| Yudhishtran Kanagasabai | M | - |
Millennium Information Technologies Ltd.
 Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | - |
| Klaus Schafer | M | 74 | 12 Jahre | |
| Catherine Sohn | M | 71 | 1 Jahre | |
| Diane Jorkasky | M | 72 | 4 Jahre | |
| Ajith Samaranayake | M | - |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | - |
| Dick L. Sherman | M | 76 | 12 Jahre | |
| Lorne Chambers | M | - |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | 9 Jahre |
| Raymond Jordt | M | 52 | 1 Jahre | |
| Anthony Blandin | M | - | 2 Jahre | |
| Antoine Shagoury | M | 54 |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | - |
| Ramamurthy Perumal | M | - |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | - |
| Karen Smith | M | 56 | 4 Jahre | |
| M. Roberts | M | 65 | 12 Jahre | |
| Ramesh Schaffter | M | - |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | - |
| Priyantha Fernando | M | 72 |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | - |
| M. Harris | M | 71 | 5 Jahre | |
| Bertrand Georges | M | - | 9 Jahre | |
| Nadarajah Murali Prakash | M | 60 |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | - |
| Nissanka Bandara Weerasekera | M | 64 |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | - |
| Satyajit N. Seneviratne | M | - |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | - |
| Karen Smith | F | - | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Philip MacNeill | M | 70 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 2 Jahre |
| Derace L. Schaffer | M | 76 |
PharmAthene, Inc. /Old/
 PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD.
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 2 Jahre |
| Eric Richman | M | 63 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 14 Jahre |
| William Brown | M | 42 | 3 Jahre | |
| Richard Eisenstadt | M | 66 | 3 Jahre | |
| Joel W. McCleary | M | 75 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD.
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | 14 Jahre |
| Jeff Jones | M | 52 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 10 Jahre |
| Christopher C. Camut | M | 61 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD.
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | - |
| J. Buchi | M | 69 | 3 Jahre | |
| Elizabeth Czerepak | F | 58 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 8 Jahre |
| Steven St. Peter | M | 57 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD.
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 3 Jahre |
| James Marino | M | 74 |
Rutgers State University of New Jersey
| 10 Jahre |
| William Enright | M | 61 | 10 Jahre | |
| Michael Schuler | M | - |
Rutgers State University of New Jersey
| 7 Jahre |
| Jeffrey Heller | M | - |
Rutgers State University of New Jersey
| 6 Jahre |
| Louis J. Freeh | M | 74 |
Rutgers State University of New Jersey
| 6 Jahre |
| Francesca M. Cook | F | 58 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD.
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 12 Jahre |
| Pete Meyers | M | 55 | 3 Jahre | |
| Wayne Morges | M | 76 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD.
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 10 Jahre |
| Wayne Pisano | M | 69 | - | |
| Thomas J. Cafferty | M | - |
Rutgers State University of New Jersey
| 7 Jahre |
| Linda L. Chang | F | 57 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 4 Jahre |
| James E. Goldschmidt | M | - | 6 Jahre | |
| Andrew Pecora | M | 67 | - | |
| George McLendon | M | - | - | |
| Stephen M. Condon | M | 64 | - | |
| Saul Zimmerman | M | - |
Rutgers State University of New Jersey
| 7 Jahre |
| Jonathan M. Kuller | M | - |
Rutgers State University of New Jersey
| 8 Jahre |
| Anthony Mahinda Thomas Weeresinghe | M | - |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | 18 Jahre |
| Douglas A. Duchak | M | - |
Rutgers State University of New Jersey
| 5 Jahre |
| Brian Markison | M | 64 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 4 Jahre |
| Michael Steinmetz | M | 75 | 5 Jahre | |
| Jim Woody | M | 81 | 9 Jahre | |
| Mark A. McKinlay | M | - | 11 Jahre | |
| Doug Onsi | M | 55 | 4 Jahre | |
| Douglas Reed | M | 70 | 6 Jahre | |
| Paul J. Schmitt | M | 73 | - | |
| Brenda D. Gavin | M | 76 | 8 Jahre | |
| Jeffrey Runge | M | 67 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | - |
| Jordan P. Karp | M | 57 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 6 Jahre |
| Valerie D. Riddle | M | 63 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD.
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | 4 Jahre |
| Lesley Russell | M | 63 | 3 Jahre | |
| Allan Harvey Cohen | M | 73 |
Rutgers State University of New Jersey
| 5 Jahre |
| Philip W. Crawford | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Scott R. Randall | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Len Krietz | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Freddie M. Kotek | M | 68 |
Rutgers State University of New Jersey
| 4 Jahre |
| Earl Hedin | M | 67 |
Rutgers State University of New Jersey
| 4 Jahre |
| Barry Frankel | M | 73 |
Rutgers State University of New Jersey
| 4 Jahre |
| Dave M. Reicher | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Bill Neugroschel | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Geza John Marx | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Harry Jay Levin | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Thomas R. Brown | M | 73 |
Rutgers State University of New Jersey
| 4 Jahre |
| Dennis Fenton | M | 72 |
Rutgers State University of New Jersey
| 3 Jahre |
| William J. Cadigan | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Stephen L. Newman | M | 73 |
Rutgers State University of New Jersey
| 4 Jahre |
| Douglas Oliver | M | 71 |
Rutgers State University of New Jersey
| 4 Jahre |
| Martin D. Cleary | M | 78 |
Rutgers State University of New Jersey
| 4 Jahre |
| E. Brian Hansberry | M | 69 |
Rutgers State University of New Jersey
| 4 Jahre |
| Lois M. van Deusen | F | 84 |
Rutgers State University of New Jersey
| 3 Jahre |
| Gary Crawford | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Alan Rubino | M | 69 |
Rutgers State University of New Jersey
| 4 Jahre |
| Vincent J. Sharkey | M | 80 |
Rutgers State University of New Jersey
| 3 Jahre |
| Joe Frank Mannello | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Matthew Appel | M | 68 |
Rutgers State University of New Jersey
| 4 Jahre |
| Lawrence W. Ruff | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| John H. Pieper | M | - |
Rutgers State University of New Jersey
| 3 Jahre |
| Greg Eisen | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
| Rob Mart | M | 68 |
Rutgers State University of New Jersey
| 4 Jahre |
| John Haley | M | 74 |
Rutgers State University of New Jersey
| 4 Jahre |
| Kenneth C. Huhn | M | - |
Rutgers State University of New Jersey
| 3 Jahre |
| J. Barry Cocoziello | M | 75 |
Rutgers State University of New Jersey
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 88 | 88,00% |
| Sri Lanka | 11 | 11,00% |
| Vereinigtes Königreich | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
